You may not be eligible for this study if the following are true:

Patients enrolled to the randomized portion of the study (arms 1 thru 3) may not be already treated on ACE or ARB therapy for hypertension or renal protection (with diabetes) at the time of enrollment. If patients are receiving ACE or ARB therapy, they may ONLY be considered for the exploratory arm, Arm 4.
Serious concomitant systemic disorders incompatible with the study (at the discretion of the investigator).
Any prior chemotherapy, radiation therapy, immunotherapy, or biologic ( targeted )
therapy for treatment of the patient's pancreatic tumor.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.